Michael Hochman, MD, MPH, board certified general internist at USC’s Keck School of Medicine, cofounder of Updates in Slow Medicine, and host of the Healthy Skeptic, MD podcast,…
Pharmacomechanical thrombolysis can be particularly effective in mitigating post-thrombotic syndrome (PTS) in younger patients, as demonstrated by data from the ATTRACT trial.
Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.
Nicotinamide riboside appears to be the best precursor supplement available to help maintain or increase NAD+ levels. All cells and tissues can use it, and at high doses…
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Although there exists no reliable government database about demand for cadavers, sources like National Geographic and The Economist have reported on data compiled from individual agencies about shortages…
